February 20, 2025

Medical Oddities: Sugar Sensors in the Heart?

Sugar sensors are found in the heart. Tea ingredient turned into hydrogel. Mind-reading is getting closer. And more.

Conexiant

February 20, 2025

Smoking Cessation Intervention Effective in Opioid Users

Providing nicotine replacement and behavioral support at opioid agonist therapy clinics helped patients halve their cigarette consumption, study finds.

Conexiant

February 20, 2025

NY Sues Major Vape Distributors Over Youth Marketing

Attorney General Letitia James files lawsuit against 13 e-cigarette companies for allegedly targeting minors with flavored nicotine products, seeking hundreds of millions in damages and penalties.

Conexiant

February 18, 2025

FDA Qualifies Two-Level RDL for AUD Trials

The drug development tool offers an alternative, clinically meaningful endpoint in clinical trials that evaluate pharmacologic treatments for alcohol use disorder.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 12, 2025

Semaglutide Reduces Alcohol Use in Trial

Diabetes and obesity drug semaglutide decreased alcohol consumption and cravings in adults with alcohol use disorder, according to phase 2 study.

Conexiant

February 12, 2025

Self-Reported Lisdexamfetamine Efficacy in Binge Eating

Patients cited diminished therapeutic effects over time, side effects, and energy crashes.

Conexiant

February 10, 2025

Guideline-Based Mental Health Treatment Gaps Identified

Researchers found significant gaps in mental health and substance use disorder treatment.

Conexiant

February 07, 2025

Long-Term Rise in Cannabis-Associated Schizophrenia Cases, Predating Legalization

Researchers found that the proportion of schizophrenia cases linked to cannabis use disorder nearly tripled post-legalization, with the highest impact among young males.

Conexiant